From left: Dr. George L. King, Joslin’s director of research, Senator Al Franken, and Joslin president John L. Brooks III.
U.S. Senator Al Franken (D – Minnesota) visited Joslin Diabetes Center in Boston to meet with newly appointed Joslin President and CEO John L. Brooks III and his staff of world-renowned researchers, doctors and nurses. The Senator toured the facility and took time to talk with many of them. A graduate of Harvard, Franken is no stranger to Boston; he met his wife while going to school here, and their first date was walking the Freedom Trail.
Joslin Diabetes Center, the world’s preeminent diabetes research and clinical care organization, has begun work on a new initiative that will focus on advancing translation strategies and efforts in the broader community. The Diabetes Prevention Initiative at Joslin aims to catalyze prevention activities; engage academic, patient advocacy, public and private sector resources; and address cost-effective efforts to bring diabetes prevention to scale while its researchers work tirelessly toward a cure.
Senator Franken has championed the fight against diabetes in Washington. A member of the Senate Committee on Health, Education, Labor and Pensions, Senator Franken introduced the Diabetes Prevention Act of 2009 with Senator Dick Lugar (R – Indiana), which was included in the health care reform law. Senator Franken has been honored by the American Diabetes Association and the YMCA of the USA for his work to reduce the spread of diabetes in America.